Patent · US Active

TATk-CDKL5 fusion proteins, compositions, formulations, and use thereof

US9290746B2 · kind B2 · utility

3Cited by

0References

20Claims

0Family size

Assignee

Universita di Bologna · IT

Inventors

Elisabetta Ciani · Bologna, IT
Franco Laccone · Stockerau, AT

Key dates

Filing date	Feb 27, 2015
Grant date	Mar 22, 2016
Priority date	—
Expiry date	Feb 27, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Y207/11022
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein are compositions and formulations containing a TATk-CDKL5 fusion protein. Also disclosed are methods of producing a TATk-CDKL5 fusion protein from vectors containing a TATk-CDKL5 cDNA and methods of transducing cells with the vectors containing a TATk-CDKL5 cDNA and the TATk-CDKL5 fusion protein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.